Cargando…
Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain
Background: There are no known medicines or vaccines to control the COVID-19 pandemic caused by SARS-CoV-2 (nCoV). Antiviral peptides are superior to conventional drugs and may also be effective against COVID-19. Hence, we investigated the SARS-CoV-2 Spike receptor-binding domain (nCoV-RBD) that int...
Autores principales: | Barh, Debmalya, Tiwari, Sandeep, Silva Andrade, Bruno, Giovanetti, Marta, Almeida Costa, Eduardo, Kumavath, Ranjith, Ghosh, Preetam, Góes-Neto, Aristóteles, Carlos Junior Alcantara, Luiz, Azevedo, Vasco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411520/ https://www.ncbi.nlm.nih.gov/pubmed/32802318 http://dx.doi.org/10.12688/f1000research.24074.1 |
Ejemplares similares
-
Comparative mangrove metagenome reveals global prevalence of heavy metals and antibiotic resistome across different ecosystems
por: Imchen, Madangchanok, et al.
Publicado: (2018) -
Linking common non-coding RNAs of human lung cancer and M. tuberculosis
por: Barh, Debmalya, et al.
Publicado: (2018) -
The Spike of SARS-CoV-2: Uniqueness and Applications
por: Kumavath, Ranjith, et al.
Publicado: (2021) -
Current Trends in Experimental and Computational Approaches to Combat Antimicrobial Resistance
por: Imchen, Madangchanok, et al.
Publicado: (2020) -
16S rRNA Gene Amplicon Based Metagenomic Signatures of Rhizobiome Community in Rice Field During Various Growth Stages
por: Imchen, Madangchanok, et al.
Publicado: (2019)